Publication | Open Access

Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators

Checkpoint ModulatorsNanomedicineMannosylated NanovaccinesCancer ImmunosurveillanceMelanomaImmunologyTherapeutic VaccineImmune-suppressing MicroenvironmentImmune Checkpoint InhibitorDermatologyImmune Cell TherapyImmunotherapyMedicineTumor Microenvironment